Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arvinas Inc
(NQ:
ARVN
)
24.01
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
24.01
Bid (Size)
3.700 (45)
Ask (Size)
30.00 (1)
Prev. Close
24.01
Today's Range
24.01 - 24.01
52wk Range
21.21 - 58.58
Shares Outstanding
53,400,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Arvinas to Participate in Upcoming Investor Conferences
June 05, 2023
From
Arvinas Inc.
Via
GlobeNewswire
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Performance
YTD
-28.03%
-28.03%
1 Month
-2.68%
-2.68%
3 Month
-20.68%
-20.68%
6 Month
-35.13%
-35.13%
1 Year
-46.44%
-46.44%
More News
Read More
Looking Into Arvinas's Return On Capital Employed
May 19, 2023
Via
Benzinga
Where Arvinas Stands With Analysts
May 08, 2023
Via
Benzinga
Warner Bros. Discovery To Rally Around 62%? Here Are 10 Other Analyst Forecasts For Monday
May 08, 2023
Via
Benzinga
Arvinas: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
Arvinas Earnings Perspective: Return On Capital Employed
February 28, 2023
Via
Benzinga
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
May 08, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 05, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas to Present at the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
Arvinas Inc.
Via
GlobeNewswire
6 Analysts Have This to Say About Arvinas
February 24, 2023
Via
Benzinga
Where Arvinas Stands With Analysts
January 31, 2023
Via
Benzinga
Where Arvinas Stands With Analysts
January 12, 2023
Via
Benzinga
Looking Into Arvinas's Return On Invested Capital
December 06, 2022
Via
Benzinga
Arvinas to Present at Stifel Targeted Oncology Day
April 21, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas Appoints Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership
April 03, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas to Participate in Upcoming Investor Conferences
February 27, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
February 23, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas to Participate in Upcoming Investor Conferences
February 06, 2023
From
Arvinas Inc.
Via
GlobeNewswire
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Via
MarketBeat
Stocks That Hit 52-Week Lows On Monday
January 09, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Via
Benzinga
Arvinas to Present at 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Arvinas Announces Changes to its Board of Directors
December 16, 2022
From
Arvinas Inc.
Via
GlobeNewswire
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
November 23, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.